Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Gustavo Freitas Alves de Arruda, Emmanuelle Tenório Albuquerque Madruga Godoi, Lara Cristiane Terra Ferreira Carreira, Rafael Willain Lopes, Gabriel Blacher Grossman, Ronaldo de Souza Leão Lima
Abstract
Severe acute respiratory syndrome coronavirus 2 infection is capable of affecting several organs. Direct viral toxicity, pro-inflammatory and pro-thrombotic induction, endothelial damage, immune imbalance, and dysregulation of the renin-angiotensin-aldosterone system are the mechanisms underlying the viral potential of multiple organ damage. The impairment of four organs stands out among severe patients: lung, heart, kidney, and endothelium. The nuclear medicine field holds accurate and safe exam techniques, such as positron emission tomography-computed tomography and scintigraphy, that allow the anatomophysiological study of the majority of human organ systems. By choosing the most appropriate method and radiopharmaceutical, analyzing the presence of inflammation, fibrosis, changes in perfusion, and function of desired organs is possible. Therefore, its use in the monitoring of patients with coronavirus disease 2019 becomes relevant, especially for monitoring sequelae. In this review, we discuss the use of Nuclear Medicine in the detection, monitoring, and therapeutic evaluation of pulmonary and extrapulmonary sequelae by coronavirus disease 2019.